Feb 2 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* WORKING THROUGH FINAL STEPS FOR ADMISSION OF ITS SHARES TO STANDARD SEGMENT OF MAIN MARKET OF LSE
* DUAL LISTING ONTO LSE EXPECTED TO BE COMPLETED IN FEB
* WILL RETAIN ITS PRIMARY LISTING ON ASX